ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025
Controllable Generation of Pathogen-Specific Antimicrobial Peptides Through Knowledge-Aware Prompt Diffusion Model.
Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Next-Generation Antimicrobial Peptides for Biofilm-Associated Infections: Engineering, Biomaterial Delivery and AI-Assisted Discovery.Antibiotics (Basel, Switzerland) · 2026Review
- AET5: A transcriptome-guided molecular generation framework with contrastive self-supervised learning.PLoS computational biology · 2026Article
- Controllable Generation of Pathogen-Specific Antimicrobial Peptides Through Knowledge-Aware Prompt Diffusion Model.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Generative models have shown considerable promise in antimicrobial peptide design; however, their ability to generate pathogen-specific peptides remains limited due to data scarcity. In this study, KPPepGen, a controllable generative framework that leverages knowledge-aware pathogen prompts derived from pre-training on Gene Ontology and pathogen knowledge graphs, which act as knowledge injections to guide a diffusion model in generating biologically plausible peptides tailored to specific pathogens, is introduced. Then, KPPepGen is extended for peptide optimization by integrating prompt-guided partial diffusion with multi-site combinatorial mutations. Experimental results show that KPPepGen can simultaneously generate valid peptides for 56 distinct pathogens, achieving high novelty, favorable physicochemical properties, and delivering over a 10% performance improvement for pathogens with limited training data. Further analysis demonstrates that KPPepGen effectively captures essential sequence and structure patterns characteristic of individual pathogens. The optimization results reveal a high success rate of 44.3% for Magainin 2, along with an average improvement of 7.6% compared to the ESM-based method, underscoring the effectiveness of KPPepGen in enhancing the overall performance of peptides. Finally, for clinically relevant pathogens such as E. coli and S. aureus, KPPepGen successfully generated nine novel peptides that exhibit strong antimicrobial activity and low cytotoxicity in the wet-lab evaluation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.